암센터 국문 논문 목록
| 학술지 |
책임저자
제1저자 |
저자,논문명,학술지명,발간일;년도;페이지:통권(Impact Factor) |
|
이인준
(중재의학연구과)
|
이인준, Hyunchul Rhim:조유리, Jin Woo Choi:Hoon Kwon, Kun Yung Kim, Byung Chan Lee, Hee Ho Chu, Dong Hyeon Lee, Han Ah Lee, Gyoung Min Kim, Jung Suk Oh, Dongho Hyun. Transarterial chemoembolization for hepatocellular carcinoma: 2023 Expert consensus-based practical recommendations of the Korean Liver Cancer Association_(CMH)
CLINICAL AND MOLECULAR HEPATOLOGY. 2023-07-01; 2023;
29(3):521~541.
IF 8.9 (2022)
|
조유리
(간담도췌장암센터)
|
|
우상명
(종양면역연구과)
|
우상명, Jang-Hwan Choi:전중원, Thanaporn Viriyasaranon:고영환, 이우진, Jae Hee Cho, Min Kyu Jung,
Seong-Hun Kim, Hyo Jung Kim. (grant 수정 필요)Annotation-Efficient Deep Learning Model for Pancreatic Cancer Diagnosis and Classification Using CT Images: A Retrospective Diagnostic Study
CANCERS. 2023-06-28; 2023;
15(13):3392~.
IF 5.2 (2022)
|
전중원
(중재의학연구과)
|
|
임명철
(자궁난소암센터)
|
임명철, Sung Jong Lee:Ji Geun Yoo:김지현, 박은영, Imhyeon Kim. Ten-year treatment outcomes of consolidation hyperthermic intraperitoneal chemotherapy for ovarian cancer (HIPEC-KOV-03R)
JOURNAL OF GYNECOLOGIC ONCOLOGY. 2023-06-27; 2023;
34:e72~.
IF 3.9 (2022)
|
Ji Geun Yoo
|
|
최범규
(종양면역연구과)
|
최범규, Ki Taek Nam:조은정, ROHITSINGH:한충용, 김선희, 박보미, 신동훈, 한성은. Correspondence: 4-1BB-4-1BBL cis-interaction contributes to the survival of self-reactive CD8+ T cell
CELLULAR & MOLECULAR IMMUNOLOGY. 2023-06-26; 2023;
20(9):1077~1080.
IF 24.1 (2022)
|
조은정
(종양면역연구과)
ROHITSINGH
(종양면역연구과)
|
|
노승배
(암전이연구과)
|
노승배, Chang Hoon Lee:노승배:Hyun Jung Byun, Boh-Ram Kim. (grant 수정 필요)LKB1/STK11 tumor suppressor reduces angiogenesis by directly interacting with VEGFR2 in tumorigenesis
BIOMOLECULES & THERAPEUTICS. 2023-06-26; 2023;
31(4):456~465.
IF 3.7 (2022)
|
노승배
(암전이연구과)
|
|
김정선
(암AI디지털헬스학과)
|
김정선:BUI Quynh Anh:Madhawa Gunathilake, 이정희, 오재환, 장희진, 손대경, Aesun Shin. Interaction between retinol intake and ISX rs5755368 polymorphism in colorectal cancer risk: a case-control study in a Korean population
SCIENTIFIC REPORTS. 2023-06-22; 2023;
13(1):10187~.
IF 4.6 (2022)
|
Anh Quynh BUI
(암관리학과)
|
|
한지연1
(치료내성연구과)
|
한지연:안병철, 박찬이:김문수, 이종목, 최진호, 김해영, 이건국, 유남희, 이영주. Tumor Microenvironment Modulation by Neoadjuvant Erlotinib Therapy and Its Clinical Impact on Operable EGFR-Mutant NSCLC
CANCER RESEARCH AND TREATMENT. 2023-06-21; 2023;
:~.
IF 4.6 (2022)
|
박찬이
(생물정보연구과)
안병철
(혈액종양내과분과)
|
|
김정선
(암AI디지털헬스학과)
|
김정선:편효진, Madhawa Gunathilake:이정희, 최일주, 김영일, Joohon Sung. Functional Annotation and Gene Set Analysis of Gastric Cancer Risk Loci in a Korean Population
CANCER RESEARCH AND TREATMENT. 2023-06-20; 2023;
:~.
IF 4.6 (2022)
|
편효진
(암의생명과학과)
Madhawa Gunathilake
(암AI디지털헬스학과)
|
|
박중원
(암진료향상연구과)
|
박중원:Sojung Han, Do Young Kim:Ho Yeong Lim, Jung-Hwan Yoon, Baek-Yeol Ryoo, Yujeong Kim, Kookhee Kim, Bo Yeon Kim, So Young Yi, Dong-Sook Kim, Do-Yeon Cho, Jina Yu, Suhyun Kim. Sorafenib for 9,923 Patients with Hepatocellular Carcinoma: An Analysis from National Health Insurance Claim Data in South Korea
GUT AND LIVER. 2023-06-19; 2023;
:~.
IF 3.4 (2022)
|
Sojung Han, Do Young Kim
|
|
Jae-Min Oh, Jeremy Soulie
|
Jae-Min Oh, Jeremy Soulie:김형준:Prescillia Lagarrigue, Fabrice Salles, Sophie Cazalbou, Christophe Drouet. Biocompatible MgFeCO3 Layered Double Hydroxide (LDH) for Bone Regeneration-Low-Temperature Processing through Cold Sintering and Freeze-Casting
BIOENGINEERING-BASEL. 2023-06-19; 2023;
10(6):734~.
IF 4.6 (2022)
|
김형준
(융합진단치료기술연구과)
|
